Repository logo
 

A high-throughput in vivo micronucleus assay for genome instability screening in mice.


Change log

Authors

Karp, Natasha A 
Ng, Bee Ling 
Jackson, Stephen P 
Adams, David J 

Abstract

We describe a sensitive, robust, high-throughput method for quantifying the formation of micronuclei, markers of genome instability, in mouse erythrocytes. Micronuclei are whole chromosomes or chromosome segments that have been separated from the nucleus. Other methods of detection rely on labor-intensive, microscopy-based techniques. Here we describe a 2-d, 96-well plate-based flow cytometric method of micronucleus scoring that is simple enough for a research technician experienced in flow cytometry to perform. The assay detects low levels of genome instability that cannot be readily identified by classic phenotyping, using 25 μl of blood. By using this assay, we have screened >10,000 blood samples and discovered novel genes that contribute to vertebrate genome maintenance, as well as novel disease models and mechanisms of genome instability disorders. We discuss experimental design considerations, including statistical power calculation, we provide troubleshooting tips and we discuss factors that contribute to a false-positive increase in the number of micronucleated red blood cells and to experimental variability.

Description

Keywords

Animals, Erythrocytes, Erythropoiesis, Flow Cytometry, Genomic Instability, High-Throughput Screening Assays, Mice, Micronucleus Tests

Journal Title

Nat Protoc

Conference Name

Journal ISSN

1754-2189
1750-2799

Volume Title

10

Publisher

Springer Science and Business Media LLC
Sponsorship
Cancer Research Uk (None)
European Research Council (268536)
Wellcome Trust (092096/Z/10/Z)
Cancer Research Uk (None)
Acknowledgments We thank M. Hitcham and N. Harman for assistance with blood collections, W. Cheng for assistance with flow cytometry during high-throughput screening and K. Dry for comments on the manuscript. R.E.M. is supported by Cancer Research UK (CRUK; project grant C20510/A12401). D.J.A. is supported by CRUK. D.J.A. and B.L.N. are supported by the Wellcome Trust. Research in the Jackson Laboratory is funded by CRUK program grant no. C6/A11224, the European Research Council and the European Community Seventh Framework Programme grant agreement no. HEALTH-F2-2010-259893 (DDResponse). Core funding is provided by CRUK (C6946/A14492) and the Wellcome Trust (WT092096). S.P.J. receives his salary from the University of Cambridge, UK, supplemented by CRUK. G.B. is funded by CRUK program grant no. C6/A11224.